Skip to main content
SpringerLink
Log in

Successful switching to brodalumab in a patient with severe psoriasis developing ixekizumab-induced eczema

  • Correspondence
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Napolitano M, Megna M, Fabbrocini G, et al. Eczematous eruption during anti-interleukin 17 treatment of psoriasis: an emerging condition. Br J Dermatol 2019; 181: 604–6.

    Article  CAS  Google Scholar 

  2. Burlando M, Cozzani E, Russo R, Parodi A. Atopic-like dermatitis after secukinumab injection: A case report. Dermatol Ther 2019; 32: e12751.

    Article  Google Scholar 

  3. Caldarola G, Pirro F, Di Stefani A, et al. Clinical and histopathological characterization of eczematous eruptions occurring in the course of anti-IL-17 treatment: a case series and review of the literature. Expert Opin Biol Ther 2020; 20: 665–72.

    Article  CAS  Google Scholar 

  4. Puşcaş AD, Cătană A, Puşcaş C, et al. Psoriasis: association of interleukin-17 gene polymorphisms with severity and response to treatment. Exp Ther Med 2019; 18: 875–80.

    PubMed  PubMed Central  Google Scholar 

  5. Suto H, Nambu A, Morita H, et al. IL-25 enhances TH17 cell-mediated contact dermatitis by promoting IL-1β production by dermal dendritic cells. J Allergy Clin Immunol 2018; 142: 1500–9.

    Article  CAS  Google Scholar 

  6. Blauvelt A, Chiricozzi A. The Immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis. Clin Rev Allergy Immunol 2018; 55: 379–90.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Dermatology, Department of Medicine of Sensory and Motor Organs, Tottori University Faculty of Medicine, Yonago, 683-8504, Japan

    Ryoko Kimura, Kazunari Sugita & Osamu Yamamoto

Authors
  1. Ryoko Kimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kazunari Sugita
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Osamu Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ryoko Kimura.

Additional information

Disclosure

Financial support: none. Conflicts of interest: none.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kimura, R., Sugita, K. & Yamamoto, O. Successful switching to brodalumab in a patient with severe psoriasis developing ixekizumab-induced eczema. Eur J Dermatol 30, 732–734 (2020). https://doi.org/10.1684/ejd.2020.3904

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2020.3904

Search

Navigation